Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography.
about
Hallmarks of glycosylation in cancerSynthetic self-adjuvanting glycopeptide cancer vaccinesClinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass SpectrometryTranscriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1Extracellular and cellular proteins of rat cells with O-glycosidically linked fucoseGlycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.Rapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1.Quantitative glycomics of human whole serum glycoproteins based on the standardized protocol for liberating N-glycans.Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoproteins.Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cellsSweetening the pot: adding glycosylation to the biomarker discovery equationSerum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients.Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.Changes in liver and L-cell plasma membranes during infection with Coxiella burnetii.Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene.Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancerThe sweet and sour of serological glycoprotein tumor biomarker quantification.Intercellular contact and cell-surface galactosyl transferase activity (cell culture-mouse-radioautography-contact inhibition-cis-and trans-galactosylation).Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase.Altered growth behavior of malignant cells associated with changes in externally labeled glycoprotein and glycolipid.Changes in membrane structure associated with cell contact.Synthesis and characterization of a novel chemically designed (Globo)3-DTPA-KLH antigen.Anionic glycopeptides and glycosaminoglycans synthesized by embryonic neural tube and neural crest.Appearance of smaller mannosyl-glycopeptides on the surface of a human cell transformed by simian virus 40Transformation of chick-embryo fibroblasts by wild-type and temperature-sensitive Rous sarcoma virus alters adenylate cyclase activityAlterations of membrane glycopeptides in human colonic adenocarcinomaCholera toxin and cell growth: role of membrane gangliosides.Protein glycosylation in cancer.A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.C-reactive protein, sialic acid and adenosine deaminase levels in serum and pleural fluid from patients with pleural effusion.Contact-inhibited revertant cell lines isolated from SV40-transformed cells. I. Biologic, virologic, and chemical properties.Relationship of transformation, cell density, and growth control to the cellular distribution of newly synthesized glycosaminoglycan.Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours.Membrane proteins of uninfected and Rous sarcoma virus- transformed avian cells.Prognostic value of serum tumor abnormal protein in gastric cancer patients.Proteins specified by herpes simplex virus. II. Viral glycoprotins associated with cellular membranes.Carbohydrate vaccines: developing sweet solutions to sticky situations?Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer.
P2860
Q26752363-FEF3B973-5D5D-4BFF-9DE9-5381F5BE956EQ26777837-1174A9FF-57D6-4AE1-9072-785C7DB9B861Q27024150-E2412482-6038-43E1-8B1D-8E7F7E73724AQ28272913-09B63B13-6F1F-49C7-ADCD-8B46335B0DA4Q28362465-2045794F-F6BB-4B8F-AFA5-AFE45D770E6AQ30382105-4CDF7F00-E63B-4096-B809-1689D25BE176Q33268341-10B4C04F-8020-422C-9AF9-AFF3CE14A978Q33285593-41835CAE-12C6-4EAF-9C71-7DB0953EB4F6Q33693811-6F4507B5-6154-4E46-B5DE-0DCC31346BC4Q33709733-58448E58-5504-455F-AB81-3679A7CDB3F2Q33768460-08C21875-34FB-4839-A147-26C284603D59Q33778489-EFCBC283-9FD5-45F5-897E-068F3FBD5E45Q34058682-A1081460-78A5-4481-999C-A5E3CA0B5785Q34075504-1E84F281-2C77-46B8-8757-81AE1A7AF0CDQ34433644-74ED6FD5-4A67-409D-9B30-CD55120EBB2EQ34565029-F689EDFC-F2C2-4CF2-BCE6-8B9684A31344Q34580285-B045A5DB-0FC1-4167-A0EF-B0D25B09D4CCQ34690694-B3D0D418-4F3D-4A66-89D9-939EF0FF3C71Q34715230-7C9A5905-39DA-4351-B94F-1C4749CFA925Q34744399-DD061D67-FD3C-425B-9AC1-E36B375C50CAQ34749630-58532FCB-60C7-40C1-B5F1-A3DDAAC07819Q34783335-E95A06D7-6C7E-463C-8A61-A739FA7E8B1DQ35011101-6F210380-9172-48AF-863D-348A8F4D1A6DQ35084013-48EF1F5E-F867-4E31-9425-652B75EFBCE6Q35100650-766D9091-B334-44B1-B5C5-E177C0DF9B31Q35120099-0D7BAAA2-36FA-42FF-BE97-0C80AE5B684FQ35129734-89E61B0F-1BFB-4F4F-A77E-51709A0DFDEDQ35413473-7E0BFA34-1706-4433-A111-A0FCFDD274ADQ35499086-6630110B-5E96-44F9-B50D-F2FBB497A6CAQ35669639-EDC73044-5CBD-404B-8B65-5B529FB8EF31Q35948424-272A968A-E2AC-45D9-98F6-D0F6C856B81CQ36192943-60C834C3-56CB-4AB2-8E0E-D830C4CC0CEDQ36198058-6311858F-3D3B-4654-B7FB-495538CC3C88Q36201697-4860EB7D-4FF6-44A7-BF9F-56A7F69C7FC1Q36592245-B90EC82C-803B-4531-8FCE-C0AAEBF41E60Q37001364-4C302E70-3FE4-4E17-953D-F762BBABE3CFQ37138787-7DC029D5-2D7B-4E6A-99D7-8915BE1096C2Q37426039-F136DF0F-28CC-4347-8444-D6BA2657BF16Q37599805-8004A26D-E99F-4250-ABD8-312BA8436FD8Q37673558-55824315-CAE1-42B1-A51D-9966C04C72D7
P2860
Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh-hant
name
Comparative studies on the car ...... es by sephadex chromatography.
@en
Comparative studies on the car ...... es by sephadex chromatography.
@nl
type
label
Comparative studies on the car ...... es by sephadex chromatography.
@en
Comparative studies on the car ...... es by sephadex chromatography.
@nl
prefLabel
Comparative studies on the car ...... es by sephadex chromatography.
@en
Comparative studies on the car ...... es by sephadex chromatography.
@nl
P2093
P356
P1433
P1476
Comparative studies on the car ...... es by sephadex chromatography.
@en
P2093
P304
P356
10.1021/BI00834A039
P407
P577
1969-06-01T00:00:00Z